Reps. Fred Upton and Diana DeGette have offered a first peak at the concepts the pharma industry can expect to see in draft biomedical reform legislation known as the 21st Century Cures Initiative.
The legislation, expected to be released in January, will “streamline the approval of drugs,” Upton and DeGette said
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?